217 related articles for article (PubMed ID: 4455117)
1. [Possibility of utilizing lymphatic leukemia L1210 as a first screening model in the primary selection of new antitumor antibiotics].
Shorin VA; Bazhanov VS
Antibiotiki; 1974 Aug; 19(8):679-84. PubMed ID: 4455117
[No Abstract] [Full Text] [Related]
2. A new antitumor antibiotic, carminomycin (NSC-180024).
Gause GF; Brazhnikova MG; Shorin VA
Cancer Chemother Rep; 1974; 58(2):255-6. PubMed ID: 4830498
[No Abstract] [Full Text] [Related]
3. [Antineoplastic activity of antibiotic 1719 from the group of diazo compounds].
Shorin VA; Averbukh LA; Bazhanov VS; Lepeshkina GN; Grinshteĭn AM
Antibiotiki; 1972 Aug; 17(8):675-80. PubMed ID: 4678532
[No Abstract] [Full Text] [Related]
4. [Study and use of antitumor antibiotics by Soviet scientists].
Gauze GF; Dudnik Iuv
Antibiotiki; 1977 Oct; 22(10):892-901. PubMed ID: 921231
[No Abstract] [Full Text] [Related]
5. [Clinical use of antitumor antibiotics].
Astrakhan VI; Garin AM
Antibiotiki; 1967 Feb; 12(2):167-72. PubMed ID: 4173165
[No Abstract] [Full Text] [Related]
6. Some antineoplastic antibiotics.
Cheng CC; Zee-Cheng KY
J Pharm Sci; 1972 Apr; 61(4):485-501. PubMed ID: 4111335
[No Abstract] [Full Text] [Related]
7. Therapeutic performance of carminomycin-cyclophosphamide against L1210 leukemia.
Avery TL; Cruze PG
Cancer Res; 1978 Sep; 38(9):2892-5. PubMed ID: 679196
[No Abstract] [Full Text] [Related]
8. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.
Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
Cancer Chemother Rep 2; 1972 Nov; 3(1):1-69. PubMed ID: 4660732
[No Abstract] [Full Text] [Related]
9. Experimental evaluation of anthracycline analogs.
Casazza AM
Cancer Treat Rep; 1979 May; 63(5):835-44. PubMed ID: 455325
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy of invasive tumors. VI. Antibiotics].
Beran M; Semonský M; Semonská S
Cesk Farm; 1979 Dec; 28(9-10):411-20. PubMed ID: 95184
[No Abstract] [Full Text] [Related]
11. [Transplantability, development and methotrexate sensitivity of mouse leukemia L1210 resistant to olivomycin].
Prokhorova EV
Antibiotiki; 1978 Jun; 23(6):553-7. PubMed ID: 677843
[TBL] [Abstract][Full Text] [Related]
12. [Comparative characteristics of the antitumor and immunodepressive activity of carminomycin on the L-1210 experimental model].
Berezina TA; Uteshev BS
Antibiotiki; 1979 Oct; 24(10):767-71. PubMed ID: 496420
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy of tumors. 3. Chemical review of natural antineoplastic agents: antibiotics and related compounds; enzymes and hormones].
Artico M
Farmaco Sci; 1974 Aug; 29(8):598-646. PubMed ID: 4136312
[No Abstract] [Full Text] [Related]
14. Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151).
Woodman RJ
Cancer Chemother Rep 2; 1974 Mar; 4(1):45-52. PubMed ID: 4826499
[No Abstract] [Full Text] [Related]
15. [Comparative experimental study of the antileukemia activity of carminomycin and rubomycin].
Khanykova OK; Vinogorova GF
Antibiotiki; 1977 Sep; 22(9):846-52. PubMed ID: 911158
[TBL] [Abstract][Full Text] [Related]
16. [Antitumor and immunodepressive action of dexamethasone on a leukemia L-1210 model].
Berezina TA; Uteshev BS; Babichev VS
Farmakol Toksikol; 1979; 42(5):537-41. PubMed ID: 488332
[TBL] [Abstract][Full Text] [Related]
17. Oral and parenteral activity of 2,2'-anhydro-1- -D-arabinofuranosyl-5-fluorocytosine against both intraperitoneally and intracerebrally inoculated mouse leukemia.
Fox JJ; Falco EA; Wempen I; Pomeroy D; Dowling MD; Burchenal JH
Cancer Res; 1972 Oct; 32(10):2269-72. PubMed ID: 4673145
[No Abstract] [Full Text] [Related]
18. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
Rose WC; Schurig JE; Huftalen JB; Bradner WT
Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
[No Abstract] [Full Text] [Related]
19. Some determinants of the therapeutic efficacy of actinomycin D (NSC-3053), adriamycin (NSC-123127), and daunorubicin (NSC-83142).
Schwartz HS
Cancer Chemother Rep; 1974; 58(1):55-62. PubMed ID: 4521481
[No Abstract] [Full Text] [Related]
20. [Studies on the mechanisms of resistance to methotrexate--with special emphasis on the change of nucleotide pools].
Nobori T; Shimizu N; Ohkubo T; Kawasaki H; Sako T; Komada M; Hirota H; Kamiya H; Sakurai M
Nihon Ketsueki Gakkai Zasshi; 1986 May; 49(3):661-9. PubMed ID: 3766065
[No Abstract] [Full Text] [Related]
[Next] [New Search]
